© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 17, 1379-1380,
September 6, 2000
© 2000 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Mathilde Krim, Ph.D., founding co-chair and chairman of the board of the American Foundation for AIDS Research, received the Presidential Medal of Freedom from President Clinton last month.
|
Krim worked for several years at the Weizmann Institute of Science in Israel researching cytogenetics and cancer-causing viruses. In 1959, she joined the research staff of Cornell University Medical School and then took a position at the Sloan-Kettering Institute for Cancer Research, where she directed its Interferon Laboratory from 1981 to 1985.
She is an adjunct professor of public health and management at the Mailman School of Public Health of Columbia University, and she is a member of the advisory council of the Office of AIDS Research at the National Institutes of Health.
The Medal of Freedom is the highest civilian award bestowed by the U.S. government. It is awarded by the President to people he deems to have made especially meritorious contributions to the security or national interests of the United States, to world peace, or to cultural or other significant public or private endeavors. Fifteen people received a medal this year.
Athayde Prize Awarded
Eduardo Caceres, M.D., clinical investigator and a surgical oncologist at the Instituto de Enfermedades Neoplasicas in Lima, Peru, was awarded the 2000 Múcio Athayde Cancer Prize by the International Union Against Cancer (UICC), Geneva.
Caceres is the chairman of the Central American Cervical Cancer and Registries Demonstration Project of the UICC. He played an important role in establishing hospital-based cancer registries in several Latin American countries and in introducing a cervical screening program in low-resource settings.
The US $100,000 Múcio Athayde Cancer Prize is intended to allow the recipient to continue his leadership in fighting cancer.
Benz Named at Dana-Farber
Edward J. Benz, Jr., M.D., has been named the next president of the Dana-Farber Cancer Institute, Boston. He will assume his new post this fall.
|
Benz is chair of the Department of Medicine at Johns Hopkins University School of Medicine and is the president of the American Society of Hematology.
At Dana-Farber, Benz will also serve as the chief executive officer of Dana-Farber/Partners Cancer Care, a collaboration of Dana-Farber, Brigham and Women’s Hospital, and Massachusetts General Hospital. He will also be principal investigator and director of of the Dana-Farber/Harvard Cancer Center and will serve on the governing board of Dana-Farber/Children’s Hospital Cancer Care.
Rosenthal Appointed
David S. Rosenthal, M.D., director and chief executive officer of Harvard University Health Services, has been appointed medical director of the soon-to-be-unveiled Leonard P. Zakim Center for Integrated Therapies at Dana-Farber Cancer Institute, Boston.
|
The new center will provide patients with complementary therapies to improve their quality of life while receiving conventional treatments, Rosenthal said. He added that the center will also provide clinical researchers the opportunity to study the safety and efficacy of these programs.
Rosenthal is a past president of the American Cancer Society and is the chairman of the ACS Alternative and Complementary Methods of Cancer Management Advisory Committee. He is a professor of medicine at Harvard Medical School and a senior physician at Brigham and Women’s Hospital, Dana-Farber, and Beth Israel Deaconess Medical Center.
The Zakim Center was named for a Dana-Farber supporter who died last December after a long battle with multiple myeloma.
Speyer Appointed
James L. Speyer, M.D., has been appointed associate director for clinical affairs of New York University’s Kaplan Comprehensive Cancer Center, New York.
In the newly created leadership position, Speyer is responsible for the coordination of clinical cancer care with the hospital’s clinical inpatient services, day hospital services, and ambulatory care centers, as well as for the oversight and medical direction of the new inpatient medical oncology unit in Tisch Hospital.
Speyer is a professor of clinical medicine at NYU School of Medicine and an attending in medicine at NYU Hospitals Center and Bellevue Hospital.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||